Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
52.50
+5.77 (12.35%)
At close: Nov 13, 2024, 4:00 PM
53.96
+1.46 (2.78%)
After-hours: Nov 13, 2024, 6:15 PM EST
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $6.26 billion as of November 13, 2024. Its market cap has increased by 1,560.81% in one year.
Market Cap
6.26B
Enterprise Value
4.68B
1-Year Change
1,560.81%
Ranking
Category
Stock Price
$52.50
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $6.26B, an increase of 521.71%. That is a compound annual growth rate of 51.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2024 | 5.58B | 731.37% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| R1 RCM | 6.03B |
| Merit Medical Systems | 5.99B |
| Stevanato Group | 5.94B |
| Inspire Medical Systems | 5.89B |
| Krystal Biotech | 5.74B |
| Arcellx | 5.57B |
| Crinetics Pharmaceuticals | 5.46B |
| Waystar Holding | 5.44B |